IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

ScinoPharm and Sundia establish alliance for contract research and manufacturing in China

9:58 AM MDT | August 7, 2013 | Deepti Ramesh

Active pharmaceutical ingredients (APIs) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says its ScinoPharm Changshu Pharmaceuticals (Changshu, China) subsidiary has entered into a strategic alliance with clinical research firm Sundia MediTech (Shanghai), to explore opportunities for collaboration in contract research and manufacturing services (Crams) in mainland China. The cooperation combines Sundia's technical know-how and capabilities in new drug R&D with ScinoPharm's process R&D and commercial production advantages, especially in the field of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa